SIGN UP
LOG IN
Why Rubrik Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
Benzinga·03/14/2025 09:08:31
Listen to the news
Shares of Rubrik, Inc. (NYSE:RBRK) rose sharply in today's pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued first-quarter guidance above estimates.
Rubrik reported quarterly losses of 61 cents per share, which beat the analyst consensus estimate for losses of 80 cents. Quarterly revenue clocked in at $258.1 million, which beat the analyst consensus estimate of $233.1 million.
Rubrik shares climbed 20.8% to $66.84 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
Gainers
- Radius Recycling, Inc. (NASDAQ:RDUS) rose 108.7% to $28.51 in pre-market trading after the company agreed to be acquired by US subsidiary of Toyota Tsusho for $30.00 per share in cash.
- Applied Optoelectronics, Inc. (NASDAQ:AAOI) gained 56.5% to $24.83 in pre-market trading after the company announced a warrant issuance agreement transaction with Amazon for 7,945,399 shares.
- MEDIROM Healthcare Technologies Inc. (NASDAQ:MRM) gained 48.6% to $0.91 in pre-market trading. MEDIROM Mother Labs executive made an additional investment in Mother Labs’ Series A financing at a pre-money valuation of JPY9 billion.
- Cellectis S.A. (NASDAQ:CLLS) gained 40.3% to $1.81 in pre-market trading after the company announced upbeat financial results for the fourth quarter.
- Bit Origin Ltd (NASDAQ:BTOG) gained 37.2% to $0.3743 in pre-market trading after declining 26% on Thursday.
- Digital Ally, Inc. (NASDAQ:DGLY) gained 23.2% to $0.0978 in pre-market trading. Digital Ally has been granted six new patents covering diverse sectors.
- TransCode Therapeutics, Inc. (NASDAQ:RNAZ) rose 19% to 0.8827. TransCode Therapeutics, on Thursday, announced Safety Review Committee approval to open a fourth cohort of its Phase I/II Clinical trial of TTX-MC138.
- DocuSign, Inc. (NASDAQ:DOCU) gained 12.2% to $83.75 in pre-market following better-than-expected fourth-quarter financial results.
- Ulta Beauty, Inc. (NASDAQ:ULTA) rose 7% to $336.26 in pre-market trading as the company reported stronger-than-expected fourth-quarter financial results. Ulta Beauty expects fiscal year 2025 revenue of $11.5 billion to $11.6 billion versus estimates of $11.67 billion, according to Benzinga Pro. The company anticipates full-year earnings of $22.50 to $22.90 per share versus estimates of $23.50 per share.
Losers
- Xponential Fitness, Inc. (NYSE:XPOF) shares fell 30.8% to $8.39 in pre-market trading after the company announced fourth-quarter results.
- Linkage Global Inc (NASDAQ:LGCB) declined 21.8% to $0.1797 in pre-market trading.
- Septerna, Inc. (NASDAQ:SEPN) dipped 21.4% to $5.02 in pre-market trading after falling 5% on Thursday.
- Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) fell 15.1% to $3.71 in pre-market trading.
- Icon Energy Corp. (NASDAQ:ICON) shares fell 14.7% to $0.1160 in pre-market trading. ICON Energy received non-compliance letter from the Nasdaq.
- Regencell Bioscience Holdings Limited (NASDAQ:RGC) fell 13.4% to $12.20 in pre-market trading. Relevant Gold closed second tranche of upsized $8.5 million non-brokered private placement led by strategic investors Kinross and Bollinger.
- ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) fell 11.8% to $0.3572 in today's pre-market trading. ImmunoPrecise Antibodies shares gained over 11% on Thursday after the company announced a strategic partnership to advance antibody-drug conjugates and bispecific antibodies for cancer.
- SenesTech, Inc (NASDAQ:SNES) shares tumbled 10% to $2.16 in pre-market trading after gaining 5% on Thursday. SenesTech recently reported better-than-expected quarterly EPS results.
- SI-BONE, Inc. (NASDAQ:SIBN) fell 8.2% to $13.51 in pre-market trading. SI-BONE recently reported better-than-expected fourth-quarter EPS results and issued FY25 sales guidance above estimates.
- XPeng Inc. (NYSE:XPEV) shares dipped 5.4% to $23.99 in pre-market trading. XPeng recenty announced to spend up to $13.8 billion on humanoid robots.
Now Read This:
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
② More than 40M Downloads Globally : data based on Webull Technologies Limited's internal statistics as of July 14, 2023.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
② More than 40M Downloads Globally : data based on Webull Technologies Limited's internal statistics as of July 14, 2023.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.